Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4501207 | 0.93 | P2RX7 (0.34) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL4519727 | 0.91 | HSD11B1 (0.35) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL14365292 | 0.86 | HSD11B1 (0.36) | EPHX2HSD11B1ROCK2 | |
| SCHEMBL4520440 | 0.85 | IDE (0.35) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL4514682 | 0.85 | GAA (0.43) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL4504367 | 0.83 | EPHX2 (0.31) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL4501748 | 0.82 | LMNA (0.35) | EPHX2HSD11B1P2RX7SMN1; SMN2ALDH1A1 | |
| SCHEMBL4506472 | 0.81 | ALDH1A1 (0.48) | P2RX7SMN1; SMN2ALDH1A1MEN1MAPT | |
| SCHEMBL13674410 | 0.80 | HSD11B1 (0.56) | EPHX2HSD11B1SMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL5132089 | 0.79 | ALDH1A1 (0.37) | EPHX2P2RX7SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264650-A1 | Prophylactic/Therapeutic Agent for Diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090264650-A1 | Prophylactic/Therapeutic Agent for Diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090264650-A1 | Prophylactic/Therapeutic Agent for Diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1864971-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2007-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264650-A1 | Prophylactic/Therapeutic Agent for Diabetes | HSD11B1, HSD17B1, HSD11B2 | EPHX2 670/4885HSD11B1 1/4885P2RX7 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.